The Israel Cancer Research Fund (ICRF), which supports cancer research at Weizmann, shares the story of Jewish hockey player Sam Fields, who was felled by aggressive CML just before turning pro. His life was saved, thanks to Gleevec, for which the Institute’s Prof. Eli Canaani helped lay the foundation.
March 08, 2017
Prof. Yosef Yarden, “among the most important cancer researchers in the world,” is receiving the 2017 Israel Prize in Life Science Research. Prof. Yarden discovered the function of an enzyme that leads to cancer, a finding that laid the foundation for the development of new cancer treatments. The Israel Prize is considered the country’s highest honor.
March 02, 2017
Read about Prof. Idit Shachar's search for an improved treatment for chronic lymphocytic leukemia and other blood cancers. She and her team discovered a blocking antibody that showed great promise in killing cancer cells in a clinical trial. Prof. Shachar also addresses the challenges of being a woman (and mom) in science. This is WeizmannViews Issue No. 45.
February 06, 2017
December 22, 2016
The fine art of mixing drug cocktails - such as for cancer treatment - is incredibly complicated, especially once you get into three or more ingredients. The numbers of possible interactions and side effects are virtually infinite. Now, a new model from the lab of Prof. Uri Alon lets scientists compare combinations of drugs to determine which work well together, and with the fewest side effects. This is a major step forward in personalized medicine.
December 07, 2016
Triple-negative breast cancer is particularly hard to treat because, as its name suggests, it lacks three receptors that usually serve as targets for anti-cancer drugs. Now, Prof. Sima Lev has identified a promising new combination therapy that not only inhibits tumor growth and survival, but gets around the problem of drug-induced resistance.
November 30, 2016
October is National Breast Cancer Awareness Month, and people everywhere are running, walking, and even shopping in support – and, at the Weizmann Institute of Science, investigating, researching, and pursuing creative new ways to attack this still-insidious, too-common disease. Our devoted scientists are developing ways to detect breast cancer early, designing more effective treatments, and better preventing it in the first place. Learn what Weizmann is doing about breast cancer – and how you can help.
October 19, 2016
September is Prostate Cancer Awareness Month and Ovarian Cancer Awareness Month, and the Weizmann Institute of Science is doing its part to not only increase understanding of both these diseases, but to develop new and better means of prevention, diagnosis, and personalized treatment.Here are just two of the many highly promising prostate and ovarian cancer projects taking place right now at Weizmann.
September 07, 2016
As Britain's Royal Pharmaceutical Society reports in its Pharmaceutical Journal, researchers working on T-cell therapies for cancer – such as Weizmann's Prof. Zelig Eshhar – were snubbed for years… until now. This thorough overview of the field's beginning – including in Prof. Eshhar's lab – and its future makes clear the importance of T cells.
August 24, 2016